Standardized quality house dust mite sublingual tablets (Acarizax®): a guide to their use as sublingual allergy immunotherapy in Europe Katherine A. Lyseng-Williamson Adis Drug Q&A 19 September 2016 Pages: 502 - 509
Eribulin mesylate in previously treated patients with advanced liposarcoma: a guide to its use Karly P. Garnock-JonesKatherine A. Lyseng-Williamson Adis Drug Q&A 27 October 2016 Pages: 510 - 514
Manage pain in paediatric oncology patients at the end of life using a multimodal interdisciplinary approach Adis Medical Writers Disease Management 02 September 2016 Pages: 515 - 520
Preventing and managing radiodermatitis may involve a range of strategies, but conclusive evidence to support any particular intervention is lacking Adis Medical Writers Disease Management 02 September 2016 Pages: 521 - 525
Treat keloids and hypertrophic scars with a combination of interventions to obtain the best results Adis Medical Writers Disease Management 28 July 2016 Pages: 526 - 529
First reports of adverse drug reactions Drug Reactions and Interactions 27 October 2016 Pages: 530 - 531
Immunogenicity of biosimilars Sanja MirkovRussell Hill Current Opinion 07 September 2016 Pages: 532 - 538
Relationship between timing of surgical antimicrobial prophylaxis and surgical site infection in a tertiary-care hospital Tejas KhakhkharRima ShahK. G. Hemavathi Original Research Article 16 September 2016 Pages: 539 - 544
